ALERTS: CARTELS - EUROPEAN UNION - COMFORT LETTER - COOPERATION - PHARMACEUTICAL SECTOR - HEALTHCARE - COVID-19

COVID-19 : The European Commission issues a comfort letter regarding cooperation between pharmaceutical producers to address the risk of shortage of medicines for the treatment of patients with Covid-19 (Medicines for Europe)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. It is recalled that on 8 April 2020, the Commission indicated that it had for the first time under Regulation 1/2003 granted an administrative letter of compatibility to an undertaking or association of undertakings. In the case in point, it concerned the former European Generic Medicines Association, now Medicines for Europe, in relation to a cooperation project between pharmaceutical producers aimed at addressing the risk of a shortage of critical hospital drugs for the treatment of patients with Covid-19. The comfort letter was adopted on the basis of the Communication on a temporary

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, COVID-19 : The European Commission issues a comfort letter regarding cooperation between pharmaceutical producers to address the risk of shortage of medicines for the treatment of patients with Covid-19 (Medicines for Europe), 8 April 2020, Concurrences N° 3-2020, Art. N° 94619, www.concurrences.com

Visites 168

All reviews